( February 28, 2013) -- A final settlement on February 12 with IDEXX Laboratories has brought antitrust enforcement to the pet healthcare marketplace. The FTC acted to break up “a monopoly in the market for point-of-care (“POC”) diagnostic products,” according to the complaint filed in December. An end to the comment period, during which the FTC logged only one comment that mainly assailed the failure of the action to recoup its cost, allowed the settlement to become final....